Manufacturer of Controlled Substances; Notice of Registration, 7477 [E9-3393]

Download as PDF Federal Register / Vol. 74, No. 30 / Tuesday, February 17, 2009 / Notices renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... Amphetamine (1100) .................... Phencyclidine (7471) .................... Cocaine (9041) ............................. Diprenorphine (9058) ................... I I II II II II The company plans to import the above listed controlled substances for non-clinical laboratory based research only. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Tocris Cookson, Inc. to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Tocris Cookson, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: February 9, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–3396 Filed 2–13–09; 8:45 am] Drug Enforcement Administration sroberts on PROD1PC70 with NOTICES Manufacturer of Controlled Substances; Notice of Registration By Notice dated October 9, 2008 and published in the Federal Register on October 17, 2008 (73 FR 61909), Penick Corporation, 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Oripavine (9330), a basic class of 19:45 Feb 13, 2009 Jkt 217001 FOR FURTHER INFORMATION CONTACT: Robin Delany-Shabazz, Designated Federal Official, OJJDP, Robin.DelanyShabazz@usdoj.gov, or 202–307–9963. Dated: February 9, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control,Drug Enforcement Administration. [FR Doc. E9–3393 Filed 2–13–09; 8:45 am] Meeting Agenda BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Office of Justice Programs [OJP (OJJDP) Docket No. 1495] AGENCY: Office of Juvenile Justice and Delinquency Prevention, Office of Justice Programs, Justice. ACTION: Notice of meeting. DEPARTMENT OF JUSTICE VerDate Nov<24>2008 controlled substance listed in schedule II. The company will use the above listed controlled substance in the manufacture of other controlled substance intermediates for sale to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Penick Corporation to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Penick Corporation to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Meeting of the Federal Advisory Committee on Juvenile Justice. BILLING CODE 4410–09–P 7477 SUMMARY: The Office of Juvenile Justice and Delinquency Prevention (OJJDP) is announcing the Spring meeting of the Federal Advisory Committee on Juvenile Justice (FACJJ), which will be held in Washington, DC March 16–17, 2009. Dates and Locations: The meeting times and locations are as follows: 1. Monday, March 16, 2009, 8 a.m. to 6 p.m., Office of Justice Programs, 810 Seventh Street, NW., Washington, DC 20531. (Open to Public) 2. Tuesday, March 17, 2009, 7:30 a.m. to 12 p.m., Oak Hill Youth Center Tour, Laurel, Maryland. (Closed NonDeliberative Session.) PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 Note: This is not a toll-free number. The Federal Advisory Committee on Juvenile Justice (FACJJ), established pursuant to Section 3(2)A of the Federal Advisory Committee Act (5 U.S.C. App.2), will meet to carry out its advisory functions under Section 223(f)(2)(C–E) of the Juvenile Justice and Delinquency Prevention Act of 2002. The FACJJ is composed of one representative from each state and territory. FACJJ duties include: reviewing Federal policies regarding juvenile justice and delinquency prevention; advising the OJJDP Administrator with respect to particular functions and aspects of OJJDP; and advising the President and Congress with regard to State perspectives on the operation of OJJDP and Federal legislation pertaining to juvenile justice and delinquency prevention. More information, including a member list, may be found at https://www.facjj.org. SUPPLEMENTARY INFORMATION: 1. Monday, March 16, 2009 • 8 a.m.–11:45 a.m. Registration; Call to Order; Remarks by the Acting OJJDP Administrator; and Overview and Discussion in Small Groups of 2009 Annual Report Final Drafts (Open Session) • 11:45 a.m.–1:45 p.m. Working Lunch/Sub Committee Meetings (Closed Session) • 1:45 p.m.–6 p.m. Sub Committee Report Outs; Review and Discussion of 2009 Annual Report Final Drafts; Meeting Adjournment (Open Session) 2. Tuesday, March 17, 2009 • 7:30 a.m.–12 p.m. Tour, Oak Hill Youth Center, Laurel, Maryland. (Closed Non-Deliberative Session). For security purposes, members of the FACJJ and of the public who wish to attend, must pre-register online at https://www.facjj.org. Should problems arise with Web registration, call Daryel Dunston at 240–221–4343. Members of the public must register by Monday, March 9, 2009. [Note: these are not tollfree telephone numbers.] Additional identification documents may be required. Space is limited. Please note: Photo identification will be required for admission to the meeting. Written Comments Interested parties may submit written comments by Monday, March 9, 2009, E:\FR\FM\17FEN1.SGM 17FEN1

Agencies

[Federal Register Volume 74, Number 30 (Tuesday, February 17, 2009)]
[Notices]
[Page 7477]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3393]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 9, 2008 and published in the Federal 
Register on October 17, 2008 (73 FR 61909), Penick Corporation, 33 
Industrial Park Road, Pennsville, New Jersey 08070, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of Oripavine (9330), a basic class of controlled 
substance listed in schedule II.
    The company will use the above listed controlled substance in the 
manufacture of other controlled substance intermediates for sale to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Penick Corporation to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Penick Corporation to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: February 9, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control,Drug 
Enforcement Administration.
 [FR Doc. E9-3393 Filed 2-13-09; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.